One gender care option ends, patients face hurdles
- A Queensland review will be led by Ruth Vine to examine hormone treatments for trans patients under 18, with findings due in November.
- The state government paused access to hormone therapies for new trans patients under 18 while the review occurs.
- Health Minister Tim Nicholls announced that people with lived experience would contribute to the review's evaluation of evidence and ethical considerations.
- Concerns exist regarding impacts on trans youth's access to care and the potential effects of the upcoming presidency.
23 Articles
23 Articles
Queensland Enlists Top Psychiatrist to Lead Review into Hormone Drugs for Children
Australia’s previous chief medical officer for mental health has been enlisted by the Queensland government to oversee a review into the use of hormone drugs for children. Professor Ruth Vine, who also previously served as Victoria’s chief psychiatrist, was announced as a “truly independent mind” to lead the review. She will consider the use of Stage 1 and Stage 2 medications for children with gender dysphoria. Stage 1 medications are better kno…
One gender care option ends, patients face hurdles
SIOUX FALLS, S.D. (KELO) - When Jack Fonder heard that gender-affirming care ended at Avera Health, he acted fast to connect transgender patients to the care they needed. "When you talk about losing access to health care, that does affect a lot of people," said Fonder, outreach facilitator for the Transformation Project. Would FEMA cut cost South Dakota millions? According to the World Health Organization (WHO), gender-affirming care is de…
Coverage Details
Bias Distribution
- 59% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage